FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Sun Pharmaceutical Industries Absorica Recall

Absorica (Isotretinoin) Capsules 30 mg USP, 30 capsules (3x10 Prescription Packs) Rx o…

Sun Pharmaceutical Industries, Inc. · Cranbury, NJ

Risk level
Class III
Reported by FDA
Dec 26, 2018
Recall ID
D-1207-2019
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled Absorica starting Dec 7, 2018. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1207-2019 on Dec 26, 2018. Reason: Subpotent Drug: Isotretinoin content results were lower than the specification limit obtained during routing product monitoring. Status: Terminated.

Why it was recalled

Subpotent Drug: Isotretinoin content results were lower than the specification limit obtained during routing product monitoring.

Product description

Absorica (Isotretinoin) Capsules 30 mg USP, 30 capsules (3x10 Prescription Packs) Rx only, Manufactured by: Galephar Pharmaceutical Research Inc. Humacao, PR 00792, Distributed by: Sun Pharmaceutical Industries Inc. Cranbury, NJ 08512, UPC 310631117313, NDC 10631-117-31 (carton) NDC10631-117-69 (prescription pack)

Lot numbers, UPCs & expiration codes

Lot: 17F28AA, Exp 1/2020

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1207-2019
Classification
Class III
Status
Terminated
Recall initiated
Dec 7, 2018
FDA report date
Dec 26, 2018
Quantity
47,520 prescription packs
Recall type
Voluntary: Firm initiated
Recalling firm
Sun Pharmaceutical Industries, Inc.

Original FDA data

Every field from FDA enforcement report D-1207-2019, exactly as published.

Show all FDA fields
City
Cranbury
State
NJ
Status
Terminated
Country
United States
Event ID
81765
Address
270 Prospect Plains Rd
Code information
Lot: 17F28AA, Exp 1/2020
Postal code
08512-3605
Report date
Dec 26, 2018
Product type
Drugs
Recall number
D-1207-2019
Classification
Class III
Recalling firm
Sun Pharmaceutical Industries, Inc.
Product quantity
47,520 prescription packs
Termination date
Jun 14, 2019
Reason for recall
Subpotent Drug: Isotretinoin content results were lower than the specification limit obtained during routing product monitoring.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Absorica (Isotretinoin) Capsules 30 mg USP, 30 capsules (3x10 Prescription Packs) Rx only, Manufactured by: Galephar Pharmaceutical Research Inc. Humacao, PR 00792, Distributed by: Sun Pharmaceutical Industries Inc. Cranbury, NJ 08512, UPC 310631117313, NDC 10631-117-31 (carton) NDC10631-117-69 (prescription pack)
Distribution pattern
Nationwide in the USA
Recall initiation date
Dec 7, 2018
Initial firm notification
Letter
Center classification date
Apr 22, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1207-2019, published Dec 26, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls